Bio Special Mergers and Acquisitions
China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
The first seven months of 2025 saw robust dealmaking in China’s biopharma and healthcare sector, even as global headwinds tempered some activity. Chi...
August 15, 2025 | Report
Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery
Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...
August 04, 2025 | News
Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery
Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...
August 04, 2025 | News
VB Spine Expands Globally with Acquisition of Stryker’s Spinal Implants Business in Australia and New Zealand
Stryker’s spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor...
August 01, 2025 | News
Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...
July 30, 2025 | News
Community Health Systems to Sell Ambulatory Lab Services to Labcorp for $195 Million in Multi-State Deal
Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a defi...
July 23, 2025 | News
DKSH Seals Strategic Acquisition of Eppendorf’s Direct Business in Thailand
DKSH has announced that it signed an agreement to acquire Eppendorf’s direct business in Thailand. Eppendorf is a leading interna...
July 21, 2025 | News
Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity
Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...
July 17, 2025 | News
Waters Corporation to Combine with BD’s Biosciences & Diagnostic Solutions, Creating a Global Life Sciences and Diagnostics Leader
Waters Corporation , a global leader in analytical instruments and software, announced it has entered into a definitive agreement to combine with BD&r...
July 15, 2025 | News
Merck & Co. (MSD Outside U.S. and Canada) to Acquire Verona Pharma for $10 Billion, Expanding Respiratory Portfolio with Ohtuvayre®
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceu...
July 04, 2025 | News
Quanterix Completes Acquisition of Akoya Biosciences, Expanding Leadership in Multi-Tissue Biomarker Detection
Quanterix Corporation, a company fueling scientific discovery through ultra-sensitive biomarker detection, announced that it has completed its previously a...
July 09, 2025 | News
Bio-Rad Launches Four New ddPCR Platforms Following Stilla Technologies Acquisition
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of four ...
July 09, 2025 | News
Merck Closes $3.4 Billion SpringWorks Acquisition to Build Rare Tumor Franchise
SpringWorks immediately adds revenue and accelerates mid- to long-term growth for Merck’s Healthcare business sector Acquisition marks the formati...
July 04, 2025 | News
Sartorius Finalises Acquisition of MatTek and Visikol to Bolster Cell Technology Portfolio
The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO ...
July 03, 2025 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
